Biotech Startups

1 investor

L7 Informatics builds L7|ESP, a unified digital platform for regulated life sciences that captures and contextualizes scientific and operational data at the point of generation and orchestrates workflows across research, development, manufacturing, and quality. It serves pharmaceutical companies, biotechs, CDMOs, CROs, diagnostics organizations, cancer centers, and research institutions with built-in LIMS, ELN, MES, and scheduling capabilities and an agentic AI layer for GxP-regulated environments.

1 investor

LJL Ventures is an early-stage venture fund that backs AI-driven therapeutics companies applying machine learning, generative biology, and computational chemistry across drug discovery, development, and clinical stages. It invests in founders building AI-native platforms for target identification, IND-enabling studies, and clinical trial design.

1 investor

LabFellows provides a software platform for lab operations management, automating supplier ordering, inventory tracking, and compliance record-keeping for biotech organizations.

1 investor

LabAdvance provides microfluidic systems, pumps, controllers, and chips for building laboratory processes. The company serves researchers and labs developing microfluidic applications.

1 investor

Labbot provides tools designed to help scientists with research and experimental work. The company serves researchers and scientific pioneers working to advance knowledge and improve the world.

1 investor

1 investor

Labomar is a company involved in food production and research, participating in the Food-4-Life research project focused on improving plant and animal raw materials for functional foods with high nutritional value while maintaining ecological sustainability.

1 investor

Majorelle is a French pharmaceutical laboratory that develops treatments, medical devices, and health products across three therapeutic areas: women's health, urology, and family health. It focuses on prevention, protection, and quality of care, aiming to make its products broadly accessible to patients.

1 investor

Labstep provides an electronic lab notebook and research data management platform for scientific and laboratory teams. The company operates in the biotech/research software space.

1 investor

Lactiga is a biotechnology company developing mucosal antibody therapies based on secretory IgA antibodies derived from human breastmilk. Its platform targets conditions such as chronic respiratory disorders, gut inflammation, and immune deficiencies through mucosal immunotherapy.

1 investor

Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.

1 investor

Laguna Biotech is a biopharmaceutical company focused on discovering and developing new therapeutic approaches through science-driven research and clinical innovation.

1 investor

LAM-X develops nanofiber materials using patented light-activated photosensitizer technology that generates reactive oxygen species to kill microorganisms, applied to antimicrobial textiles and medical devices such as intravenous catheter dressings. It also produces life science products including a biodegradable universal Western Blot membrane (VerdiBlot) for protein analysis, with applications spanning medical devices, food packaging, crop protection, and water filtration.

1 investor

Lamin provides a lineage-native lakehouse platform for biological R&D that enables scientists to query, trace, and validate complex biological datasets across academia, biotech, and pharma. The platform integrates data versioning and cataloging capabilities to close the feedback loop between experimental results and machine learning models.

1 investor

Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions. A spin-off from INSERM and the University of Strasbourg's Regenerative Nanomedicine unit, it has EMA and ANSM authorization for a Phase I clinical trial in Strasbourg, France.

1 investor

1 investor

Lantheus is a radiopharmaceutical company that develops, manufactures, and commercializes radiodiagnostics and radiotherapeutics for cancer detection, treatment and monitoring, as well as precision diagnostics for non-oncologic diseases.

1 investor

Laprophan is a Moroccan pharmaceutical company that develops, manufactures, and markets over 1,000 drug references across eight therapeutic areas, operating the country's first pharmaceutical R&D center. It sells products in more than 50 countries and holds international patents, with a focus on accessible therapeutic solutions.

1 investor

Lara DaTx is a company focused on developing targeted treatments for unmet medical needs.

1 investor

Lario Therapeutics develops first-in-class precision medicines aimed at disease-modifying treatments for severe neurological disorders, including developmental and epileptic encephalopathies and Parkinson's disease. Its pipeline is built on genetically validated targets, focusing on early childhood syndromes and adult neurodegenerative conditions.

1 investor

LASE Innovation provides single-cell tracking and barcoding technology that captures time-dimension data to train AI/ML models for biological research. The company commercializes optical cell barcoding developed at Massachusetts General Hospital and MIT, enabling researchers to track millions of cells across time and conditions.

1 investor

LastMinute automates healthcare scheduling using AI and predictive analytics to optimize staffing levels for nurses and healthcare facilities. The platform addresses workforce management challenges in the healthcare industry.

1 investor

Latent Knowledge builds LitView, a semantic search and knowledge-graph tool that lets researchers search and reason over biomedical literature as a connected network of papers rather than a keyword-ranked list. It serves academic and enterprise research teams with features for field orientation, novelty validation, evidence-cited synthesis, and keeping literature reviews current.

1 investor